Zobair M. Younossi, MD, MPH


Outcomes of Liver Transplantation by Insurance Type in the United States

April 07, 2020

Patients with publicly sponsored insurance who were listed for liver transplantation have worse wait-list and posttransplant outcomes, as shown using the US Scientific Registry of Transplant Recipients (2001-2017).

Impact of Hepatitis C Virus and Insurance Coverage on Mortality

February 07, 2019

The Medicaid population has significantly higher hepatitis C virus (HCV) prevalence and mortality rates than patients with private insurance. These data must be considered when policy makers assess providing additional support to Medicaid programs for HCV elimination.